EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Comparison of Bleeding Risk Scores in Atrial Fibrillation Patients on Direct-Acting Oral Anticoagulants: A Real-Life Study

Yusuf İnci, Hasan Ali Barman, Doğaç Okşen, Ömer Doğan, Abdullah Ömer Ebeoğlu, Sercan Çayırlı, Mehmet Rasih Sonsöz, Mehmet Nail Bilen, Sait Mesut Doğan

Koşuyolu Heart Journal · 01.07.2026 · 29 (2) · 114-120

DOI: 10.51645/khj.2026.600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Koşuyolu Heart Journal, online erschienen am 08.06.2026. Verfasst von Yusuf İnci und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hemorrhagic complications continue to be a major clinical challenge among individuals with atrial fibrillation (AF) receiving direct-acting oral anticoagulants (DOACs). This research sought to evaluate and contrast the accuracy of various risk assessment models in forecasting bleeding incidents within this specific patient cohort.

Methods

We enrolled 447 subjects diagnosed with AF who were prescribed DOAC therapy (including apixaban, dabigatran, edoxaban, or rivaroxaban). By retrospectively reviewing institutional electronic health records, we computed the ORBIT, ATRIA, and HEMORR 2 HAGES risk indices for each participant. The main outcome measures were defined as the occurrence of clinically relevant minor or major hemorrhages. Consequently, we analyzed how accurately these scoring systems could foresee the specified endpoints.

Results

The cohort’s average age stood at 75.6±10.1 years, comprising predominantly women (62.2%). During a 12-month observation period, 6.7% of the participants (n=30) encountered one or more major hemorrhagic events. When forecasting severe bleeding, the ATRIA, ORBIT, and HEMORR 2 HAGES frameworks exhibited comparable predictive accuracies without any statistically notable variations. Upon conducting a multivariate logistic regression, independent variables linked to a heightened likelihood of bleeding encompassed prior hemorrhagic episodes (odds ratio [OR]: 3.101, p=0.019) and the presence of heart failure (OR: 2.028, p=0.009). In addition, anemia emerged as a significant factor (OR: 0.366, p=0.049), alongside elevated evaluations in both the HEMORR 2 HAGES (OR: 1.535, p=0.006) and ORBIT (OR: 1.849, p

Zitieren

APA

İnci, Y., Barman, H. A., Okşen, D., Doğan, Ö., Ebeoğlu, A. Ö., Çayırlı, S., Sonsöz, M. R., Bilen, M. N., & Doğan, S. M. (2026). Comparison of Bleeding Risk Scores in Atrial Fibrillation Patients on Direct-Acting Oral Anticoagulants: A Real-Life Study. Koşuyolu Heart Journal, 29(2), 114-120. https://doi.org/10.51645/khj.2026.600

Vancouver

İnci Y, Barman HA, Okşen D, Doğan Ö, Ebeoğlu AÖ, Çayırlı S, et al. Comparison of Bleeding Risk Scores in Atrial Fibrillation Patients on Direct-Acting Oral Anticoagulants: A Real-Life Study. Koşuyolu Heart Journal. 2026;29(2):114-120. doi:10.51645/khj.2026.600

BibTeX
@article{nci2026,
  author = {İnci, Yusuf and Barman, Hasan Ali and Okşen, Doğaç and Doğan, Ömer and Ebeoğlu, Abdullah Ömer and Çayırlı, Sercan and Sonsöz, Mehmet Rasih and Bilen, Mehmet Nail and Doğan, Sait Mesut},
  title = {Comparison of Bleeding Risk Scores in Atrial Fibrillation Patients on Direct-Acting Oral Anticoagulants: A Real-Life Study},
  journal = {Koşuyolu Heart Journal},
  year = {2026},
  volume = {29},
  number = {2},
  pages = {114--120},
  doi = {10.51645/khj.2026.600}
}
Kostenlos starten →